Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

RUNX1 cooperates with FLT3-ITD to induce leukemia.

Behrens K, Maul K, Tekin N, Kriebitzsch N, Indenbirken D, Prassolov V, Müller U, Serve H, Cammenga J, Stocking C.

J Exp Med. 2017 Mar 6;214(3):737-752. doi: 10.1084/jem.20160927. Epub 2017 Feb 17.

2.

Essential control of early B-cell development by Mef2 transcription factors.

Herglotz J, Unrau L, Hauschildt F, Fischer M, Kriebitzsch N, Alawi M, Indenbirken D, Spohn M, Müller U, Ziegler M, Schuh W, Jäck HM, Stocking C.

Blood. 2016 Feb 4;127(5):572-81. doi: 10.1182/blood-2015-04-643270. Epub 2015 Dec 10.

3.

Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.

Harder L, Eschenburg G, Zech A, Kriebitzsch N, Otto B, Streichert T, Behlich AS, Dierck K, Klingler B, Hansen A, Stanulla M, Zimmermann M, Kremmer E, Stocking C, Horstmann MA.

J Exp Med. 2013 Oct 21;210(11):2289-304. doi: 10.1084/jem.20130497. Epub 2013 Sep 30.

4.

Runx1 is essential at two stages of early murine B-cell development.

Niebuhr B, Kriebitzsch N, Fischer M, Behrens K, Günther T, Alawi M, Bergholz U, Müller U, Roscher S, Ziegler M, Buchholz F, Grundhoff A, Stocking C.

Blood. 2013 Jul 18;122(3):413-23. doi: 10.1182/blood-2013-01-480244. Epub 2013 May 23.

5.

Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells.

Windhorst S, Kalinina T, Schmid K, Blechner C, Kriebitzsch N, Hinsch R, Chang L, Herich L, Schumacher U, Mayr GW.

Int J Cancer. 2011 Sep 15;129(6):1300-9. doi: 10.1002/ijc.25782. Epub 2011 Jan 6.

Supplemental Content

Loading ...
Support Center